densitas® intelliMammo™ is a breakthrough A.I. platform, comprising densitas® qualityai™, densitas® densityai™, and densitas® riskai™, that provides a comprehensive solution for patient and process management in screening mammography. densitas® intelliMammo™ provides clinical image quality, breast density, and cancer risk assessments that are accessible on-demand at point-of-care by radiologists and radiological technologists, and through a web-based embedded analytics platform by diagnostic imaging managers, QC technologists, and health system administrators. The Densitas® team is dedicated to making top in class A.I. solutions for breast cancer screening in the world, and to moving the needle for better patient care.
densitas® densityai™ generates automated and reliably reproducible breast density assessments from standard clinical use mammograms that align with the ACR BI-RADS® 5th edition density classification scale.
densitas® qualityai™ produces automated and standardized clinical image quality assessment supporting compliance with the FDA MQSA EQUIP.
densitas® riskai™ provides automated rapid breast cancer risk assessment based on image-derived features; results are reliably reproducible and less prone to bias.
About Densitas®:
Densitas® is a global leader in artificial intelligence solutions for mammography and breast cancer screening designed to reduce health care costs and increase quality and appropriateness of care. Densitas® designs solutions that align with value-based care delivery models, focusing on precision breast health, mammography quality, workflow efficiencies, national mammography reporting standards, FDA MQSA EQUIP compliance, and radiological technologist training.
SOURCE Densitas
Back to HCB News